Efficacy and safety of the Chaixiong Qiwei granule for tension-type headache: study protocol for a randomised controlled trial
Open Access
Abstract
Introduction Tension-type headache (TTH) is the most prevalent headache disorder worldwide. Although current treatments for TTH are beneficial, they are not without adverse effects. Chaixiong Qiwei granule (CXQW) is an experienced prescription medicine for TTH management. This study will evaluate the efficacy and safety of CXQW for the treatment of TTH. Methods and analysis This study will be a multicentre, randomised, double-blind, placebo-controlled trial. A total of 148 eligible participants will be divided into the intervention (CXQW treatment) and control (placebo treatment) groups. The primary outcome will be the reduction in the number of headache days (headache-days reduction) within 9–12 weeks after randomisation, while secondary outcomes will include the number of headache days, headache intensity, responder rate, drug consumption for acute treatment, quality of life and symptoms related to traditional Chinese medicine use based on a symptom-observation table. This protocol describes the design of the randomised controlled trial. Ethics and dissemination The study design was approved by the Institutional Review Board of Human Research at Xiyuan Hospital, China Academy of Chinese Medical Sciences (No. 2020XLA030-2). Trial registration number ChiCTR2100042514.Keywords
Funding Information
- Capital Health Research and Development of Special Fund (No. 2020-2-4173)
- the National TCM Leading Personnel Support Program (No. 12)
- Talents Cultivation Program of National Administration of Traditional Chinese Medicine (ZYYCXTD-C-202007)
- Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences (CI2021B006)
- Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences (No. CI2021B006)
This publication has 30 references indexed in Scilit:
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd editionCephalalgia, 2018
- Traditional Uses, Origins, Chemistry and Pharmacology of Bombyx batryticatus: A ReviewMolecules, 2017
- Tricyclic and Tetracyclic Antidepressants for the Prevention of Frequent Episodic or Chronic Tension-Type Headache in Adults: A Systematic Review and Meta-AnalysisJournal of General Internal Medicine, 2017
- Complementary and integrative medicine in the management of headacheBMJ, 2017
- Tension‐Type Headache – The Normal and Most Prevalent HeadacheHeadache: The Journal of Head and Face Pain, 2017
- EFNS guideline on the treatment of tension‐type headache – Report of an EFNS task forceEuropean Journal of Neurology, 2010
- Guidelines for Controlled Trials of Drugs in Tension-Type Headache: Second EditionCephalalgia, 2009
- Pharmacodynamic action and mechanism of volatile oil from Rhizoma Ligustici Chuanxiong Hort. on treating headachePhytomedicine, 2009
- Tension-type headache: current research and clinical managementThe Lancet Neurology, 2008
- Medication-overuse headache: similarities with drug addictionTrends in Pharmacological Sciences, 2005